OTCPK:MJNE

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

MJ Holdings, Inc., through its subsidiaries, operates in the medical marijuana business in Nevada. More Details


Snowflake Analysis

Mediocre balance sheet and overvalued.


Similar Companies

Share Price & News

How has MJ Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: MJNE's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

2.6%

MJNE

-4.8%

US Pharmaceuticals

-4.1%

US Market


1 Year Return

-51.8%

MJNE

1.5%

US Pharmaceuticals

12.0%

US Market

Return vs Industry: MJNE underperformed the US Pharmaceuticals industry which returned 1.5% over the past year.

Return vs Market: MJNE underperformed the US Market which returned 12% over the past year.


Shareholder returns

MJNEIndustryMarket
7 Day2.6%-4.8%-4.1%
30 Day32.6%-5.0%-0.2%
90 Day38.3%-4.9%2.8%
1 Year-51.8%-51.8%4.1%1.5%14.6%12.0%
3 Yearn/a19.9%10.9%35.8%26.8%
5 Yearn/a30.7%15.6%75.2%55.6%

Price Volatility Vs. Market

How volatile is MJ Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is MJ Holdings undervalued compared to its fair value and its price relative to the market?

1.71x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate MJNE's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate MJNE's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: MJNE is unprofitable, so we can't compare its PE Ratio to the US Pharmaceuticals industry average.

PE vs Market: MJNE is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate MJNE's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: MJNE is good value based on its PB Ratio (1.7x) compared to the US Pharmaceuticals industry average (2.9x).


Next Steps

Future Growth

How is MJ Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

14.9%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as MJ Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has MJ Holdings performed over the past 5 years?

-63.8%

Last years earnings growth


Earnings and Revenue History

Quality Earnings: MJNE is currently unprofitable.

Growing Profit Margin: MJNE is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if MJNE's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare MJNE's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MJNE is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (18.7%).


Return on Equity

High ROE: MJNE has a negative Return on Equity (-124.73%), as it is currently unprofitable.


Next Steps

Financial Health

How is MJ Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: MJNE's short term assets ($3.5M) exceed its short term liabilities ($1.6M).

Long Term Liabilities: MJNE's short term assets ($3.5M) exceed its long term liabilities ($3.3M).


Debt to Equity History and Analysis

Debt Level: MJNE's debt to equity ratio (36.6%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if MJNE's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if MJNE has enough cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if MJNE has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is MJ Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate MJNE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MJNE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if MJNE's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MJNE's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of MJNE's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Roger Bloss (63 yo)

0.083

Tenure

Mr. Roger J. Bloss is the Director at MJ Holdings, Inc. since April 1, 2019 and also serves as its Interim Chief Executive Officer since September 2020. He serves as Board Adviser at InsuraGuest Technologi ...


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

MJ Holdings, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: MJ Holdings, Inc.
  • Ticker: MJNE
  • Exchange: OTCPK
  • Founded:
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$10.455m
  • Shares outstanding: 65.76m
  • Website: https://www.mjholdingsinc.com

Number of Employees


Location

  • MJ Holdings, Inc.
  • 3275 South Jones Boulevard
  • Las Vegas
  • Nevada
  • 89146
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MJNEOTCPK (Pink Sheets LLC)YesCommon Stock USUSDDec 2017

Biography

MJ Holdings, Inc., through its subsidiaries, operates in the medical marijuana business in Nevada. It offers cultivation management, licensing support, production management, and asset and infrastructure d ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/10/30 03:50
End of Day Share Price2020/10/29 00:00
Earnings2019/09/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.